Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies

J Neuroimmunol. 2011 Oct 28;239(1-2):105-7. doi: 10.1016/j.jneuroim.2011.08.014. Epub 2011 Sep 10.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / therapeutic use
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / pathology
  • Complementary Therapies
  • Drug Resistance, Multiple
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Male
  • Neurons / drug effects
  • Neurons / pathology
  • Remission Induction
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Infliximab